Chairman of the Board and Chief Executive Officer | Read more
Chief Executive Officer, International Data Group, Inc. | Read more
Vice Chairman of the Board and President | Read more
Former President, Horizon Group USA, Inc. | Read more
Former Chief Executive Officer Covance, Inc. | Read more
Former Chief Financial Officer, United Parcel Service, Inc. | Read more
Lead Director, Henry Schein, Inc.; and Retired Chairman, Ernst & Young, LLP (now known as EY LLP) | Read more
Former Vice President and Chief Information Officer, Harvard University | Read more
Executive Vice President, Chief Strategic Officer | Read more
Former Executive Vice President, Chief Financial Officer, Henry Schein, Inc. | Read more
Senior Advisor, Manatt Health Solutions; and Former President and Chief Executive Officer, Visiting Nurse Service of New York | Read more
Former President and Chief Executive Officer of Blue Cross Blue Shield Association | Read more
Former Chief Executive Officer, Reliant Pharmaceuticals, Inc.; and Former President of U.S. Human Health, Merck & Co. | Read more
Managing Director of Tuckson Health Connections, LLC, and Founder, Black Coalition Against COVID-19 | Read more
Chairman of the Board and Chief Executive Officer
Since 1989, Stanley M. Bergman has been Chairman of the Board and CEO of Henry Schein, Inc., a Fortune 500® company and the world's largest provider of health care products and services to office-based dental and medical practitioners, with approximately 22,000 Team Schein Members worldwide and operations or affiliates in 32 countries and territories. Henry Schein is a member of the S&P 500® index. In 2021, the Company's sales reached $12.4 billion. Henry Schein has been a Fortune World's Most Admired Company for 21 consecutive years.
Mr. Bergman serves as a board member or advisor for numerous institutions including New York University College of Dentistry; the University of Pennsylvania School of Dental Medicine; University of the People; Hebrew University; Tel Aviv University; the University of the Witwatersrand Fund; The World Economic Forum’s Health Care Governors; the Business Council for International Understanding; the Japan Society; and the Metropolitan Opera. Mr. Bergman is an honorary member of the American Dental Association and the Alpha Omega International Dental Society. Mr. Bergman is a recipient of the Ellis Island Medal of Honor; the CR Magazine Corporate Responsibility Lifetime Achievement Award; the 2017 CEO of the Year award by Chief Executive Magazine; Honorary Doctorates from The University of the Witwatersrand, Western University of Health Sciences, Hofstra University, A.T. Still University’s Arizona School of Dentistry and Oral Health, Case Western Reserve University and Farmingdale State College (SUNY), and The Hebrew University of Jerusalem; and Honorary Fellowship from King’s College London - Dental Institute and the International College of Dentists.
Stan and Dr. Marion Bergman and their family are active supporters of organizations fostering the arts, higher education, cultural diversity and grassroots health care and sustainable entrepreneurial economic development initiatives in the United States, Africa and other developing regions of the world.
Mr. Bergman is a graduate of The University of the Witwatersrand in South Africa, and is a South African Chartered Accountant and a NYS Certified Public Accountant (CPA). To read Mr. Bergman’s articles on LinkedIn, please click here.
View more »
Chief Executive Officer, International Data Group, Inc.
Mr. Ali has been a director of Henry Schein, Inc. since February 2021. He currently serves as Chief Executive Officer and a director at International Data Group, Inc. (IDG), a technology media, events, and research company.
Mr. Ali has extensive experience successfully growing and leading technology companies through strategic transformations. Prior to IDG, Mr. Ali was President and CEO of Carbonite, Inc., a provider of SaaS security and data protection for businesses and individuals. Prior to that, Mr. Ali served as Chief Strategy Officer at Hewlett-Packard (HP) where he played a pivotal role in the company's turnaround and led the decision process to split HP into two companies. He also served as President of Avaya Client Services and in various executive roles at IBM.
He is currently the lead director for iRobot Corporation’s board of directors and is a former member of the board of directors of Carbonite and City National Bank. He was named 2018 CEO of the Year by the Massachusetts Technology Leadership Council, member of 2018 Public Board of the Year by National Association of Corporate Directors New England, 2020 and 2018 100 Most Powerful People in Boston by Boston Magazine, 2011 All-Star by Massachusetts High Tech magazine, 2008 40-Under-40 by Boston Business Journal, and was a finalist in America’s prestigious 1988 National Science Talent Search.
Mr. Ali holds a B.S. in computer engineering, a B.A. in history, and a master’s degree in electrical engineering, each from Stanford University.
Vice Chairman of the Board and President
Mr. Breslawski has been with the Company since 1980, in his current position as Vice Chairman since March 2018, President since 2005, and as a director since 1992. He is also a member of our Executive Management Committee. Mr. Breslawski held the position of Chief Executive Officer of our Global Dental Group from 2005 to March 2018. He also held the position of Executive Vice President and President of U.S. Dental from 1990 to 2005, with primary responsibility for the North American Dental Group. Between 1980 and 1990, Mr. Breslawski held various positions with us, including Chief Financial Officer, Vice President of Finance and Administration and Corporate Controller.
Mr. Breslawski partners with our senior leadership team to address corporate and strategic priorities and brings to the Company’s Board of Directors management and leadership experience. The Board of Directors is aided by Mr. Breslawski’s understanding of the health care business and his keen business acumen, leadership ability and interpersonal skills. He has served as Chairman of the Board of the American Dental Trade Association, Chairman of the Board of the Dental Trade Alliance Foundation, and President of the Dental Dealers of America. He is also a former member of the Leadership Council, School of Dental Medicine at Harvard University, a former board member of the Dental Life Network (formerly the National Foundation of Dentistry for the Handicapped), a former member of the Board of Governors for St. John’s University, and a former trustee of Long Island University.
Prior to joining Henry Schein, Mr. Breslawski was a certified public accountant at the national professional services firm BDO Seidman, LLP. He received his degree in accounting from St. John's University.
Former President, Horizon Group USA, Inc.
Ms. Derby has been a director of Henry Schein, Inc. since February 2021. Most recently, she was President of Horizon Group USA, Inc., a wholesaler of arts and crafts components, from 2016 until June 2020.
Ms. Derby brings to Henry Schein considerable experience across a wide range of industries and markets, and particular expertise in human resources, compensation, and supply chain management. Prior to Horizon Group, Ms. Derby had a 15-year career at Toys "R" Us, rising to the position of President of Babies "R" Us and, ultimately, Vice Chairman of Toys "R" Us from 2013 until 2015. Before joining Toys "R" Us, Ms. Derby practiced corporate and employment law at Whirlpool Corporation and a large law firm in Michigan.
She is a current member of the board of directors of Carrols Restaurant Group, Inc. and a former member of the board of directors of the Vitamin Shoppe, Inc.
Ms. Derby received a B.A. in general studies with a concentration in economics from Harvard University and received an MBA and law degree from the University of Notre Dame.
Former Chief Executive Officer Covance, Inc.
Mr. Herring has been a director of Henry Schein, Inc. since 2016. He served as Chief Executive Officer of Covance, Inc. from 2005 to 2015 and as Chairman of its Board of Directors from 2006 until its acquisition by Laboratory Corporation of America, Inc. in 2015. Prior to joining Covance, Mr. Herring held a variety of senior leadership positions with Caremark International and American Hospital Supply Corporation over the course of his 19 years with the combined companies. He currently serves on the nonprofit board for University Medical Center of Princeton and previously served on the board of the Association of Clinical Research Organizations, of which he served as chairman. He is a former director of Team Health Holdings, Inc.
Mr. Herring received a Bachelor of Science in marketing from Louisiana State University.
Former Vice President and Chief Information Officer, Harvard University
Ms. Margulies has been a director of Henry Schein, Inc. since 2018. She served as Vice President and University Chief Information Officer at Harvard University from 2010 to 2021 and was responsible for information technology strategy, policies, and services that support the University’s mission of teaching, learning, and research. She also led Harvard University Information Technology (HUIT), which provides IT services to 30,000 educators, students, and staff and oversees a $200 million budget and 700 staff.
Before returning to Harvard, where she had been Assistant Provost and Executive Director for Information Systems in the late 1990s, Ms. Margulies was Assistant Secretary for Information Technology and CIO for the Commonwealth of Massachusetts. In this capacity, she developed and implemented a statewide strategic plan for IT and oversaw consolidation of a vast patchwork of agency IT organizations, operations, data centers, and networks into a coherent statewide structure. Prior to her service with the Commonwealth, Ms. Margulies was founding Executive Director of Massachusetts Institute of Technology’s OpenCourseWare, the institution’s internationally acclaimed initiative to publish the teaching materials for their entire curriculum openly and freely over the Internet.
As a member of the Massachusetts Technology Collaborative Board (a quasi-state agency overseeing economic development in the Commonwealth), Ms. Margulies participated in the Governor’s Trade mission to Israel to recruit cybersecurity companies to Massachusetts. She has also been recognized as the 2015 Boston CIO Leader of the Year by the Boston Business Journal along with the Boston CIO Leadership Association and, in 2017, was named by IDG Enterprises to the 2017 CIO Hall of Fame in CIP Magazine.
Former Chief Financial Officer, United Parcel Service, Inc.
Mr. Kuehn has been a director of Henry Schein, Inc. since 2016. He was Chief Financial Officer of United Parcel Service, Inc. ("UPS"), a global leader in logistics, from 2008 until 2015. Prior to his appointment as CFO, Mr. Kuehn was Senior Vice President, Worldwide Sales and Marketing, leading the transformation of the sales organization to improve the global customer experience. Mr. Kuehn was UPS's first Vice President of Investor Relations, taking the company public in 1999 in one of the largest IPOs in U.S. history. Since he joined UPS as a driver in 1977, Mr. Kuehn's UPS career included leadership roles in sales and marketing, engineering, operations, and strategic cost planning.
Mr. Kuehn is also a director at LocatorX, a privately held company that provides accurate, inexpensive, and flexible tracking technology to companies across a variety of industries. He is on the board of the Sustainability Accounting Standards Board and is a former director of NCR Corporation.
Mr. Kuehn attended Yale University, received a Master of Business Administration from the University of Miami, and completed an advanced management program from the Wharton School of Business.
Lead Director, Henry Schein, Inc.; and Retired Chairman, Ernst & Young, LLP (now known as EY LLP)
Mr. Laskawy has been a director of Henry Schein, Inc. since 2002, and has served as Lead Director since 2012. Mr. Laskawy spent 40 years at Ernst & Young (now known as EY LLP), retiring as Chairman and CEO of the Company in 2001. Under his leadership, the firm expanded into a global leader in assurance, tax, transaction, and advisory services.
Mr. Laskawy joined Ernst & Young in 1961 after graduating from the Wharton School of the University of Pennsylvania with a Bachelor's degree in Economics. Progressing through the ranks of the audit services practice, he was admitted to the firm's partnership in 1971. He became Managing Partner of the New York Office in 1981, and in 1985 was named Vice Chairman and Managing Partner of the New York Region and a member of the firm's Management Committee. Mr. Laskawy became Chairman and CEO of Ernst & Young in 1994 and held that position until his retirement.
Mr. Laskawy currently serves on the Board of Directors of Lazard Ltd. and is Chairman of its audit committee and is a member of its compensation committee. He is also a director at Loews Corporation and is a member of its audit committee.
Mr. Laskawy served on the American Institute of Certified Public Accountants to review and update rules regarding auditor independence. In 2006 and 2007, he served as Chairman and Vice Chairman of the International Accounting Standards Committee Foundation, which was created by the Securities and Exchange Commission and sets accounting standards in more than 100 countries, and he served as a member of the 1999 Blue Ribbon Committee on Improving the Effectiveness of Corporate Audit Committees. Mr. Laskawy has also served on the Board of Directors of General Motors Corporation and was the Non-Executive Chairman of Federal National Mortgage Association (Fannie Mae).
Executive Vice President, Chief Strategic Officer
Mr. Mlotek has been with Henry Schein, Inc. since 1994, serving in his current position as Executive Vice President and Chief Strategic Officer since 2012 and as a director since 1995. He is also a member of the Executive Management Committee. In his current role, Mr. Mlotek has three main priorities: worldwide merger and acquisition activity for the Company; business development, including important supplier partnership arrangements; and worldwide strategic planning.
Prior to holding his current position, Mr. Mlotek served as the Company's Senior Vice President of Corporate Business Development, and before that, upon joining the Company in 1994, was Vice President, General Counsel, and Secretary. Prior to joining Henry Schein, Mr. Mlotek was a partner in the law firm of Proskauer Rose, LLP and counsel to the Company, specializing in mergers and acquisitions, corporate reorganizations, and tax law. At Proskauer, since 1989, Mr. Mlotek worked very closely with Henry Schein on various corporate matters. Prior to joining Proskauer, Mr. Mlotek was a partner in the law firm of Feit & Ahrens.
Mr. Mlotek graduated from the Columbia University School of Law with high honors in 1980. He received an LL.M. in Taxation from New York University School of Law in 1985, also graduating with honors. Mr. Mlotek graduated summa cum laude with a B.S. degree in accounting from the Herbert Lehman University of City College of New York in 1977. Mr. Mlotek has been active in various charitable organizations, many of which help the perpetuation of the Yiddish language and culture. From 1996-2000, he served on the Conference of Presidents of Major American Jewish Organizations. Mr. Mlotek is a member of the New York State Bar Association.
Former Executive Vice President, Chief Financial Officer, Henry Schein, Inc.
Mr. Paladino has been a Member of the Board of Directors of Henry Schein, Inc. since 1992. He served as Executive Vice President and Chief Financial Officer at Henry Schein from 2000 to 2022. From 1993 to 2000, he served as Senior Vice President and Chief Financial Officer, from 1990 to 1992, he served as Vice President and Treasurer, and from 1987 to 1990, he served as Corporate Controller. A certified public accountant, Mr. Paladino was with BDO Seidman, LLP as Manager, General Audit and Consulting Services prior to joining Henry Schein in 1987.
During his tenure as Executive Vice President and Chief Financial Officer of Henry Schein, Mr. Paladino's responsibilities included corporate oversight of business units and direct responsibility for Corporate Finance, which included financial reporting, financial planning, treasury, investor relations, internal audit, risk management, and taxation. He was also responsible for Henry Schein Financial Services, which provides financial business services to Henry Schein's customers and works with the Corporate Business Development Group on Mergers and Acquisition activities.
Mr. Paladino led the Company through the corporate reorganization and separation from Schein Pharmaceutical in 1993 and through the IPO process in 1995.
Mr. Paladino is a member of the American Institute of CPAs, NYS Society of CPAs and the Institute of Management Accountants. He serves as Board Member for MSC Industrial Supply Co. and is a member of its audit committee and compensation committee.
He also served as a Nasdaq Listing and Hearing Review Council member. The Listing and Hearing Review Council provides advice to the Board of Directors of The Nasdaq Stock Market LLC on issues relating to listing rule and policy changes and enhancements that will protect investors and the integrity of the Nasdaq Stock Market, while ensuring the consistent and fair application and enforcement of the listing rules, procedures and policies of Nasdaq.
Mr. Paladino is the recipient of the following recognitions and awards:
Mr. Paladino holds a bachelor of business administration degree from Bernard M. Baruch College.
Senior Advisor, Manatt Health Solutions; and Former President and Chief Executive Officer, Visiting Nurse Service of New York
Ms. Raphael has been a director of Henry Schein, Inc. since 2012. She currently serves as a Senior Advisor for Manatt Health Solutions. Ms. Raphael served as the President and Chief Executive Officer of the Visiting Nurse Service of New York from 1989 to 2011. Prior to this, she held executive positions at Mt. Sinai Medical Center and in New York City government.
Ms. Raphael has served on the Federal Bipartisan Commission on Long Term Care, the Medicare Payment Advisory Commission (MedPAC), the New York State Medicaid Redesign Team, and was an Advanced Leadership Fellow at Harvard University. She is the Chair of the Board of the Long Term Quality Alliance and a board member of the New York eHealth Collaborative, which is implementing a statewide, standardized platform for the exchange of health information.
She chaired the National Quality Forum's Post-Acute, Long Term Care, and Hospice Workgroup, which brought together stakeholders to recommend quality measures as federal programs move to public reporting and value-based purchasing. She is co-chair of its Attribution Committee and a member of its All-Cause Admissions and Readmissions Standing Committee. She also co-chaired the West Health Advisory Council on Emergency Department to Home-Based Healthcare.
Ms. Raphael currently serves on several non-profit boards including the Primary Care Development Corporation, the Medicare Rights Center, the SCAN Foundation, Commonwealth Care Alliance, the Kaiser Permanente School of Medicine, and in 2016, completed her term as Chair of the national AARP board. She is also a member of several advisory boards, including the Harvard School of Public Health's Policy and Management Executive Council, the New York City Age-Friendly Commission, the New York State Quality Advisory Committee, and Honor Technology, Inc.'s Advisory Board. Ms. Raphael co-edited the book "Home Based Care for a New Century," was a Visiting Fellow at the King's Fund in the United Kingdom, and was listed in Crain's New York Business 50 Most Powerful Women in 2009.
Ms. Raphael has an MPA from Harvard University's Kennedy School of Government.
Former President and Chief Executive Officer of Blue Cross Blue Shield Association
Mr. Serota has been a director of Henry Schein, Inc. since December 2021. Most recently, he was President and CEO of Blue Cross Blue Shield Association (BCBSA), a national federation of 35 independent, community-based, and locally operated Blue Cross Blue Shield companies, from 1996 until January 2021.
Mr. Serota brings to Henry Schein considerable expertise in health care insurance and public policy. Prior to joining BCBSA, Mr. Serota was President and CEO of Chicago-based Rush Prudential Health Plans, where he led the integration of Rush-Presbyterian-St. Luke's Medical Center Health Plans and The Prudential. Earlier in his career, Mr. Serota also created and led Physicians Preferred Health Inc., a Missouri-based physician-hospital organization, and served as an administrator at Hillcrest Medical Center in Tulsa, Oklahoma. His public policy activity includes having served on the Policy Committee of the White House Conference on Aging under President George W. Bush, and as a charter member of the American Health Information Community, a federally chartered commission formed to advance health information, also by the appointment of President Bush.
Among civic leadership roles, Mr. Serota served on the CEO Advisory Board for Building a Healthier Chicago, and is a member of the Advisory Board for the Schaeffer Center at the University of Southern California.
Mr. Serota earned a B.S. from Purdue University, a master’s in health administration and planning from the Washington University School of Medicine, and an honorary Doctor of Science from Purdue University.
Former Chief Executive Officer, Reliant Pharmaceuticals, Inc.; and Former President of U.S. Human Health, Merck & Co.
Dr. Sheares has been a director of Henry Schein, Inc. since 2010. He most recently served as Chief Executive Officer of Reliant Pharmaceuticals, Inc., Inc., leading that company from January 2007 through its acquisition by GlaxoSmithKline plc in December 2007. Prior to joining Reliant, Dr. Sheares served as President of U.S. Human Health for Merck & Co., Inc. from 2001 until 2006, the culmination of a 19-year career with that company.
Dr. Sheares is the former chair of the Board of Directors of the National Pharmaceutical Council, which focuses on broadly communicating the economic, clinical, and societal value of pharmaceuticals. He also serves as a director of Honeywell International and is a member of its management development and compensation committee and retirement plan committee. Dr. Sheares is also a director and Chairman of the compensation committee of The Progressive Corporation.
Dr. Sheares holds a bachelor's degree in chemistry from Fisk University and earned his doctorate in biochemistry from Purdue University. He completed his postdoctoral training as a Lucille P. Markey Scholar and was a National Institutes of Health Postdoctoral Fellow at the Massachusetts Institute of Technology.
Managing Director of Tuckson Health Connections, LLC, and Founder, Black Coalition Against COVID-19
Dr. Tuckson is currently the Managing Director of Tuckson Health Connections, LLC. He is also the Founder of the Black Coalition Against COVID-19. Prior to Tuckson Health Connections, Dr. Tuckson enjoyed a long tenure as Executive Vice President and Chief of Medical Affairs of United Health Group from 2006 until 2014.
Dr. Tuckson previously served as Senior Vice President, Professional Standards of the American Medical Association, Commissioner of Public Health for the District of Columbia, Senior Vice President of the March of Dimes Birth Defects Foundation, and President of the Charles R. Drew University of Medicine and Science. Additionally, he has been appointed to leadership roles at the National Academy of Medicine, and has been a member of numerous federal advisory committees and corporate, non-profit, and academic boards, including his current service on the board of trustees of Howard University, where he serves as Chair of the Health Sciences Committee. The Board values Dr. Tuckson’s more than 35 years of experience as a health care professional, his recognition as a leader in his field, and his engagement in nearly every sector of the health and medical care industries.
Dr. Tuckson currently serves on the board of directors of CTI BioPharma Corp., a corporation concerned with the development of cancer pharmaceuticals (and is Chair of its nominating and governance committee and a member of its audit committee). He also serves on the board of directors of Adverum Biotechnologies, Inc., a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. During the past five years, Dr. Tuckson served as a director of LifePoint Health, Inc.
Dr. Tuckson was recognized several times as one of the "50 Most Influential Physician Executives" by Modern Healthcare Magazine, named as one of the "100 Most Powerful Executives in Corporate America" by Black Enterprise Magazine in 2009, and as "Washingtonian of the Year" by Washingtonian Magazine in 1998. He is also the author of "The Doctor in the Mirror," an ongoing book and online senior patient activation and education project.
Dr. Tuckson received a B.S. from Howard University and an M.D. from Georgetown University School of Medicine. Dr. Tuckson completed the University of Pennsylvania Hospital’s General Internal Medicine Residency and Fellowship programs, where he was also a Robert Wood Johnson Foundation Clinical Scholar studying at the Wharton School of Business.